XOMA Royalty (XOMA) Interest Coverage Ratio Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.00% |
| Jun 30, 2025 | 28.55% |
| Mar 31, 2025 | 15.88% |
| Dec 31, 2024 | 18.97% |
| Sep 30, 2024 | -44.56% |
| Jun 30, 2024 | 0.20% |
| Mar 31, 2024 | -21.25% |
| Dec 31, 2023 | -54.13% |
| Sep 30, 2023 | -16.10% |
| Jun 30, 2023 | -23.74% |
| Mar 31, 2023 | -105.55% |
| Dec 31, 2022 | -10.34% |
| Sep 30, 2022 | -17.70% |
| Jun 30, 2022 | -21.83% |
| Mar 31, 2022 | -18.16% |
| Dec 31, 2021 | 75.89% |
| Sep 30, 2021 | 57.71% |
| Jun 30, 2021 | 65.11% |
| Mar 31, 2021 | -9.76% |
| Dec 31, 2020 | 109.15% |